Good
Mostly Aligned
Patient Risk:
Low
Summary
The AI response’s included claims are well supported by the provided label excerpts (indication, key administration restriction, GI warnings, severe symptoms guidance, and a stated contraindication). However, the response does not evaluate several other label areas (e.g., warnings/precautions beyond GI, adverse reactions details, monitoring/administration specifics like meals/water and swallowing whole, dosing ranges/division rules), leaving material coverage gaps relative to a full label-alignment check.
Category Scores
Accurate Statements
Potassium chloride extended-release tablets are indicated for treatment and prophylaxis of hypokalemia with or without metabolic alkalosis when diet or diuretic dose reduction is insufficient.
Supported by 1 INDICATIONS AND USAGE: “indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.”
If serum potassium concentration is <2.5 mEq/L, intravenous potassium should be used instead of oral supplementation.
Supported by 2 DOSAGE AND ADMINISTRATION (2.1): “If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation.”
Potassium chloride extended-release tablets should not be taken on an empty stomach due to potential gastric irritation.
Supported by 2 DOSAGE AND ADMINISTRATION (2.1): “Do not take on an empty stomach because of its potential for gastric irritation.”
Solid oral potassium chloride can cause ulcerative and/or stenotic gastrointestinal lesions, particularly with prolonged mucosal contact.
Supported by 5 WARNINGS AND PRECAUTIONS (5.1): “can produce ulcerative and/or stenotic lesions… particularly when the drug remains in contact with the gastrointestinal mucosa for a prolonged period of time.”
Severe vomiting, abdominal pain, distention, or gastrointestinal bleeding requires discontinuation of potassium chloride extended-release tablets and consideration of ulceration, obstruction, or perforation.
Supported by 5 WARNINGS AND PRECAUTIONS (5.1): “discontinue… and consider possibility of ulceration, obstruction or perforation.”
Potassium chloride is contraindicated in patients on triamterene or amiloride.
Supported by 4 CONTRAINDICATIONS: “contraindicated in patients on triamterene or amiloride.”
Unsupported Statements
Contradictions
Important Omissions
Did not assess/cover key dosing instructions from the provided label excerpts, including typical dosing ranges (treatment 40–100 mEq/day; prevention 20 mEq/day) and the maximum-per-dose/division rule (dosages >20 mEq/day should be divided so no more than 20 mEq in a single dose).
Importance:
Moderate
Did not assess/cover administration instructions from the provided label excerpts beyond 'not on an empty stomach' (e.g., take with meals and with a glass of water or other liquid; swallow whole without crushing/chewing/sucking).
Importance:
Moderate
Did not assess/cover additional monitoring and administration details from the provided label excerpts (e.g., periodic serum potassium monitoring during maintenance therapy; attention to acid-base balance/volume status/electrolytes and ECG in certain patients).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
All evaluated claims that imply safety-related actions/limits (e.g., IV substitution threshold, empty stomach guidance, GI discontinuation triggers, and contraindication) are supported by the provided label excerpts. Main limitation is incomplete coverage of other label safety/administration elements rather than incorrect claims.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Incomplete label coverage: key dosing/admin/monitoring details present in the provided excerpts were not evaluated or included.
Suggested Improvement
Extend the evaluation to include the provided label’s dosing ranges and per-dose division rule, the full administration instructions (meals/liquid; swallow whole), and the monitoring/ECG/acid-base/electrolyte guidance where included in the excerpts.